{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:56:58Z","timestamp":1791302218938,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion Medicine Reviews"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.tmrv.2011.01.002","type":"journal-article","created":{"date-parts":[[2011,3,5]],"date-time":"2011-03-05T14:12:00Z","timestamp":1299334320000},"page":"206-216","source":"Crossref","is-referenced-by-count":71,"title":["Banking of Pluripotent Adult Stem Cells as an Unlimited Source for Red Blood Cell Production: Potential Applications for Alloimmunized Patients and Rare Blood Challenges"],"prefix":"10.1016","volume":"25","author":[{"given":"Thierry","family":"Peyrard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Bardiaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ladan","family":"Kobari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Lapillonne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Andreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Douay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmrv.2011.01.002_bb0005","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.tmrv.2004.06.005","article-title":"Progress in modulating the RBC membrane to produce transfusable universal\/stealth donor RBCs","volume":"18","author":"Garratty","year":"2004","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0010","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1046\/j.1537-2995.2000.40111290.x","article-title":"Transfusion to blood group A and O patients of group B RBCs that have been enzymatically converted to group O","volume":"40","author":"Kruskall","year":"2000","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.seminhematol.2006.09.013","article-title":"Red cell substitutes","volume":"44","author":"Winslow","year":"2007","journal-title":"Semin Hematol"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0020","unstructured":"United Nations, Department of Economic and Social Affairs, Population Division (2007). World Population Prospects: The 2006 Revision, Highlights, Working Paper No. ESA\/P\/WP.202."},{"key":"10.1016\/j.tmrv.2011.01.002_bb0025","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nbt0502-467","article-title":"Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo","volume":"20","author":"Neildez-Nguyen","year":"2002","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0030","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nbt1047","article-title":"Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells","volume":"23","author":"Giarratana","year":"2005","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0035","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/MOH.0b013e32832bcaa2","article-title":"Erythroid cells in vitro: from developmental biology to blood transfusion products","volume":"16","author":"Migliaccio","year":"2009","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0040","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ccc.2008.12.008","article-title":"Stem cells\u2013A source of adult red blood cells for transfusion purposes: Present and future","volume":"25","author":"Douay","year":"2009","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0045","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-1-59745-060-7_8","article-title":"Ex vivo generation of human red blood cells: a new advance in stem cell engineering","volume":"482","author":"Douay","year":"2009","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0050","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.tibtech.2009.03.008","article-title":"Blood cell manufacture: current methods and future challenges","volume":"27","author":"Timmins","year":"2009","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0055","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s12185-008-0062-y","article-title":"Ex vivo large-scale generation of human red blood cells from cord blood CD34(+) cells by co-culturing with macrophages","volume":"87","author":"Fujimi","year":"2008","journal-title":"Int J Hematol"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0060","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/nbt1245","article-title":"Efficient enucleation of erythroblasts differentiated in vitro from hematopoietic stem and progenitor cells","volume":"24","author":"Miharada","year":"2006","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0065","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1111\/j.1537-2995.2008.01828.x","article-title":"In vitro clinical-grade generation of red blood cells from human umbilical cord blood CD34+ cells","volume":"48","author":"Baek","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0070","doi-asserted-by":"crossref","first-page":"10716","DOI":"10.1073\/pnas.191362598","article-title":"Hematopoietic colony-forming cells derived from human embryonic stem cells","volume":"98","author":"Kaufman","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0075","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1182\/blood-2006-02-003327","article-title":"Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures","volume":"108","author":"Vodyanik","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0080","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/j.exphem.2005.09.003","article-title":"Differentiation of human embryonic stem cells into hematopoietic cells by coculture with human fetal liver cells recapitulates the globin switch that occurs early in development","volume":"33","author":"Qiu","year":"2005","journal-title":"Exp Hematol"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0085","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1182\/blood-2003-03-0832","article-title":"Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells","volume":"102","author":"Chadwick","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0090","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1182\/blood-2003-07-2563","article-title":"VEGF-A165 augments erythropoietic development from human embryonic stem cells","volume":"103","author":"Cerdan","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0095","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1182\/blood-2004-11-4522","article-title":"Hematopoietic differentiation of human embryonic stem cells progresses through sequential hematoendothelial, primitive, and definitive stages resembling human yolk sac development","volume":"106","author":"Zambidis","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0100","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1182\/blood-2006-09-047704","article-title":"Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures","volume":"109","author":"Kennedy","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0105","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1182\/blood-2005-11-011874","article-title":"Definitive-like erythroid cells derived from human embryonic stem cells coexpress high levels of embryonic and fetal globins with little or no adult globin","volume":"108","author":"Chang","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0110","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1182\/blood-2007-07-102087","article-title":"Globin switches in yolk sac-like primitive and fetal-like definitive red blood cells produced from human embryonic stem cells","volume":"111","author":"Qiu","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0115","doi-asserted-by":"crossref","first-page":"13087","DOI":"10.1073\/pnas.0802220105","article-title":"Generation of functional erythrocytes from human embryonic stem cell-derived definitive hematopoiesis","volume":"105","author":"Ma","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0120","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1182\/blood-2008-05-157198","article-title":"Biological properties and enucleation of red blood cells from human embryonic stem cells","volume":"112","author":"Lu","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0125","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0130","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0135","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nature06534","article-title":"Reprogramming of human somatic cells to pluripotency with defined factors","volume":"451","author":"Park","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0140","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1634\/stemcells.2008-0922","article-title":"Hematopoietic and endothelial differentiation of human induced pluripotent stem cells","volume":"27","author":"Choi","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0145","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1172\/JCI38591","article-title":"Generation of mature human myelomonocytic cells through expansion and differentiation of pluripotent stem cell-derived lin-CD34+CD43+CD45+ progenitors","volume":"119","author":"Choi","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0150","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/stem.321","article-title":"Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence","volume":"28","author":"Feng","year":"2010","journal-title":"Stem Cells"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0155","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.3324\/haematol.2010.023556","article-title":"Red blood cells generation from human induced pluripotent stem cells: perspectives for transfusion medicine","volume":"95","author":"Lapillonne","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0160","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tmrv.2006.11.004","article-title":"Ex vivo production of human red blood cells from hematopoietic stem cells: what is the future in transfusion?","volume":"21","author":"Douay","year":"2007","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0165","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1537-2995.2006.00708.x","article-title":"Anneke Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity","volume":"46","author":"Schonewille","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0170","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1537-2995.2006.00764.x","article-title":"Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures?","volume":"46","author":"Schonewille","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0175","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/j.1537-2995.2006.00900.x","article-title":"Relative immunogenicity of Fya and K antigens in a Caucasian population, based on HLA class II restriction analysis","volume":"46","author":"Noizat-Pirenne","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0180","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1111\/j.1537-2995.2007.01433.x","article-title":"Clinical predictors of alloimmunization after red blood cell transfusion","volume":"47","author":"Bauer","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0185","unstructured":"Rapport annuel d'h\u00e9movigilance 2008, Agence Fran\u00e7aise de S\u00e9curit\u00e9 Sanitaire des Produits de Sant\u00e9 (AFSSAPS). http:\/\/www.afssaps.fr\/var\/afssaps_site\/storage\/original\/application\/8cd23a5cc28ff824c5ea95e1974b6b19.pdf"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0190","first-page":"254","article-title":"Alloimmunization following blood transfusion","volume":"113","author":"Walker","year":"1989","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0195","first-page":"42","article-title":"Multiple red cell transfusions and alloimmunization. Experience with 6996 antibodies detected in a total of 159,262 patients from 1985 to 1993","volume":"119","author":"Hoeltge","year":"1995","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0200","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1537-2995.2007.01505.x","article-title":"Association between alloantibody specificity and autoantibodies to red blood cells","volume":"48","author":"Ahrens","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0205","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.tracli.2009.07.001","article-title":"The red blood cell antigen terminologies","volume":"16","author":"Peyrard","year":"2009","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0210","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1046\/j.1537-2995.1990.30690333485.x","article-title":"Incidence of red cell antibodies after multiple blood transfusion","volume":"30","author":"Fluit","year":"1990","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0215","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.tracli.2008.02.001","article-title":"The rare blood groups: a public health challenge","volume":"15","author":"Peyrard","year":"2008","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0220","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1423-0410.2008.01084.x","article-title":"Donors with a rare pheno (geno) type","volume":"95","author":"Reesink","year":"2008","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0225","doi-asserted-by":"crossref","first-page":"13","DOI":"10.21307\/immunohematology-2019-224","article-title":"Transfusion of rare cryopreserved red blood cell units stored at \u221280\u00b0C degrees: the French experience","volume":"25","author":"Peyrard","year":"2009","journal-title":"Immunohematology"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0230","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/MOH.0b013e3283316bed","article-title":"How to find, recruit and maintain rare blood donors","volume":"16","author":"Nance","year":"2009","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0235","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1046\/j.1537-2995.2003.00565.x","article-title":"Antibodies to high-frequency antigens may decrease the quality of transfusion support: an observational study","volume":"43","author":"Seltsam","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0240","first-page":"143","article-title":"Transfusion and obstetrical safety of people with a rare blood group","volume":"16","author":"Peyrard","year":"2010","journal-title":"H\u00e9matologie"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0245","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1182\/blood.V94.12.4337","article-title":"DAR, a new RhD variant involving exons 4, 5, and 7, often in linkage with ceAR, a new Rhce variant frequently found in African blacks","volume":"94","author":"Hemker","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0250","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2156-4-14","article-title":"RHD allele distribution in Africans of Mali","volume":"4","author":"Wagner","year":"2003","journal-title":"BMC Genet"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0255","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1111\/j.1537-2995.2006.00907.x","article-title":"Mailing of a sickle cell disease educational packet increases blood donors within an African American community","volume":"46","author":"Price","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0260","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1046\/j.1537-2995.2002.00120.x","article-title":"The contribution of sociodemographic, medical, and attitudinal factors to blood donation among the general public","author":"Boulware","year":"2002","journal-title":"Transfusion 42;"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0265","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1423-0410.2009.01209.x","article-title":"Blood group genotyping: from patient to high-throughput donor screening","volume":"97","author":"Veldhuisen","year":"2009","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0270","first-page":"2","article-title":"Rare gems: null phenotypes of blood groups","volume":"8","author":"Flegel","year":"2010","journal-title":"Blood Transfus"},{"key":"10.1016\/j.tmrv.2011.01.002_bb0275","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.bbrc.2009.11.058","article-title":"Generation of human induced pluripotent stem cells from a Bombay individual: moving towards \u201cuniversal-donor\u201d red blood cells","volume":"391","author":"Seifinejad","year":"2010","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Transfusion Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796311000034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796311000034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T20:27:44Z","timestamp":1712262464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887796311000034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0887796311000034"],"URL":"https:\/\/doi.org\/10.1016\/j.tmrv.2011.01.002","relation":{},"ISSN":["0887-7963"],"issn-type":[{"value":"0887-7963","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}